Living Between Scans: Uncertainty, Hope and Life After a Dementia Diagnosis
In this guest article, ADI Board Member and dementia advocate, Bill Yeates, shares his post diagnosis journey, discussing the hopes and challenges of life between scans.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
ADI Launches the Alzheimer’s Disease Atlas
Access the world's first of its kind platform highlighting how countries diagnose, treat and support people living with dementia.
From Ibiza to Iceland: Strengthening responses to dementia across Europe
November 2025 saw a plethora of activity across the European region. From engagements in Ibiza, Reykjavík and Manchester, UK. ADI took part in key events with its members throughout the region to promote greater awareness and activity, towards addressing the growing burden of dementia.
ADI’s European Region Roundup for October 2025
From Switzerland to Italy, ADI has taken part in key engagements on the European continent that convened industry leaders, clinicians, specialists, researchers, regulators, policymakers, advocates, people living with dementia and their carers to bring new insights and strategies to light.
UN Member States recognise dementia as a leading NCD
After two years of dedicated and persistent advocacy by ADI, dementia will, for the first time, be formally recognised within the new UN Political Declaration on noncommunicable diseases (NCDs) and mental health, as a leading NCD.
Deputies’ Health and Budget Commissions build momentum towards Argentina’s Dementia National Plan – One Step Closer to Becoming Law
On 13 August, Argentina’s Health and Budget Committees approved the Dementia Bill, marking a major step towards the country’s first National Dementia Plan. Congressman and neuroscientist Facundo Manes urged the government to allocate funding for the law, which now moves to the full Chamber of Deputies before reaching the Senate. ADI welcomes this development as Argentina advances towards making dementia a national health priority.
Asia Pacific Spotlight: High-level meeting in Hanoi and Lyon
This month, ADI’s Regional Director for the Asia Pacific, DY Suharya, partook in a number of important meetings and events both in Lyon, France at the WHO Academy, and in Hanoi, Vietnam, alongside Vietnam International Organisation for Better Ageing (VIOBA), who are currently partaking in ADI’s Membership Development Programme.
Strengthening Dementia Advocacy in Mexico: ADI Advances Strategic Partnerships for National Implementation
As part of ADI's ongoing regional commitment to dementia policy, Diego Aguilar, Regional Director for the Americas, completed a high-impact country visit to Mexico that combined academic engagement, civil society coordination, and high-level government and industry dialogue.
EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
UK National Health Service to deny free Alzheimer’s treatments
The National Institute for Health and Care Excellence (NICE) has concluded that the benefits from two treatments for early Alzheimer's Disease, donanemab and lecanemab, remain too small to justify the additional cost. Consequently, free access to these Alzheimer's treatments will not be provided in the UK.